4//SEC Filing
ZACCARDELLI DAVID 4
Accession 0001193125-26-006427
CIK 0001833214other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:40 PM ET
Size
5.6 KB
Accession
0001193125-26-006427
Insider Transaction Report
Form 4
ZACCARDELLI DAVID
Director
Transactions
- Award
Stock Option (right to buy)
2026-01-05+240,000→ 240,000 totalExercise: $3.74Exp: 2036-01-05→ Common Stock (240,000 underlying)
Footnotes (2)
- [F1]Represents the inaugural grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in three equal annual installments on January 5, 2027, January 5, 2028 and January 5, 2029.
- [F2]This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001627642
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:40 PM ET
- Size
- 5.6 KB